AGC Biologics vs BSP Pharmaceuticals: CDMO Comparison
How does AGC Biologics compare to BSP Pharmaceuticals for ADC manufacturing?
Side-by-side comparison of AGC Biologics and BSP Pharmaceuticals on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- AGC Biologics has more FDA inspections on record (4 vs 1) — a deeper regulatory paper trail.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
On a 13-modality CDMO landscape, both AGC Biologics and BSP Pharmaceuticals qualify as ADC manufacturers; AGC Biologics carries the higher composite Signal Score for ADC programs in this comparison.
What to evaluate for ADC programs
Both AGC Biologics and BSP Pharmaceuticals qualify as ADC CDMOs. When choosing between them for ADC programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
HPAPI containment
Look for OEB-5 (sub-microgram occupational exposure band) suites for handling cytotoxic payloads end-to-end. Containment maturity is the floor for credible commercial ADC work.
Linker-payload chemistry on file
Match the CDMO's payload + linker experience to your program. MMAE / vc-MMAE is the most common; PBDs, calicheamicin, Dxd-class topoI inhibitors, and TLR agonists each carry distinct handling and analytical demands.
Commercial bioconjugation track record
Has the CDMO conjugated a commercially-approved ADC? Track record on Polivy, Padcev, Trodelvy, Enhertu, Tivdak, Elahere, Adcetris, Mylotarg, Besponsa, Lumoxiti, Blenrep, etc. is a strong qualifying signal.
Integrated DS + DP
Bioconjugation produces ADC drug substance; you'll also need sterile fill-finish for drug product. Confirm whether the CDMO covers both or partners — both routes work, but integrated is faster on transfer.
Frequently asked: AGC Biologics vs BSP Pharmaceuticals
How does AGC Biologics compare to BSP Pharmaceuticals for ADC manufacturing?
On CDMO Signal's composite Signal Score, AGC Biologics is 78/100 and BSP Pharmaceuticals is 78/100; AGC Biologics has 4 FDA inspections on record vs 1 for BSP Pharmaceuticals; European coverage is 27 active EMA+MHRA certificates for AGC Biologics vs 15 for BSP Pharmaceuticals. Both are tracked in the CDMO Signal directory as ADC CDMOs. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, AGC Biologics or BSP Pharmaceuticals?
Both AGC Biologics and BSP Pharmaceuticals maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. AGC Biologics has 4 FDA inspections on record; BSP Pharmaceuticals has 1.
How do AGC Biologics and BSP Pharmaceuticals compare on European GMP coverage?
AGC Biologics holds 27 active EMA GMP certificates and 0 MHRA / UK certificates. BSP Pharmaceuticals holds 15 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is more active in clinical-stage manufacturing — AGC Biologics or BSP Pharmaceuticals?
AGC Biologics is matched to 2 ClinicalTrials.gov records as a manufacturing partner; BSP Pharmaceuticals is matched to 0. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.
Which is better for ADC manufacturing — AGC Biologics or BSP Pharmaceuticals?
Both AGC Biologics and BSP Pharmaceuticals are tagged as ADC CDMOs in our directory, so both are credible options for ADC programs. The most important differentiator for ADC selection is typically hpapi containment: Look for OEB-5 (sub-microgram occupational exposure band) suites for handling cytotoxic payloads end-to-end. Containment maturity is the floor for credible commercial ADC work. Review each CDMO's profile and inspection record before shortlisting.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →